Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
29681-21-8
31290-76-3
53609-62-4
102867-56-1
52788-79-1
77078-22-9
4021-50-5 | 4-Trifluoromethylthiobenzaldehyde | AA0035W1 | MFCD00129191
612-19-1 | 2-Ethylbenzoic acid | AA0035Z7 | MFCD00045838
85684-61-3 | 3-(Difluoromethoxy)benzaldehyde | AA00362M | MFCD00236222
66494-26-6 | Methyl 1-(tert-butoxycarbonylamino)cyclopropanecarboxylate | AA003665 | MFCD11520021
877-09-8 | 2,4,5,6-Tetrachloro-m-xylene | AA003693 | MFCD00000544
832114-10-0 | 4-(3-(Dimethylamino)propylcarbamoyl)phenylboronic acid, pinacol ester | AA0036CB | MFCD05864306
78-70-6 | Linalool | AA0036FC | MFCD00008906
7120-41-4 | Methyl 5-bromo-2-methoxybenzoate | AA0036IJ | MFCD06203656
98071-16-0 | 1-Aminocyclobutanecarboxylic acid HCl | AA0036LR | MFCD08752285
979-32-8 | 3-Hydroxy-17β-valeroyloxyestra-1,3,5(10)-trien | AA0036P8 | MFCD00056541